全文获取类型
收费全文 | 53484篇 |
免费 | 5293篇 |
国内免费 | 1322篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 1945篇 |
妇产科学 | 903篇 |
基础医学 | 3443篇 |
口腔科学 | 836篇 |
临床医学 | 6189篇 |
内科学 | 18901篇 |
皮肤病学 | 194篇 |
神经病学 | 1130篇 |
特种医学 | 578篇 |
外科学 | 2962篇 |
综合类 | 9268篇 |
现状与发展 | 7篇 |
一般理论 | 3篇 |
预防医学 | 3952篇 |
眼科学 | 995篇 |
药学 | 5666篇 |
39篇 | |
中国医学 | 2666篇 |
肿瘤学 | 356篇 |
出版年
2024年 | 45篇 |
2023年 | 1156篇 |
2022年 | 1235篇 |
2021年 | 2616篇 |
2020年 | 2501篇 |
2019年 | 2244篇 |
2018年 | 2217篇 |
2017年 | 2160篇 |
2016年 | 2352篇 |
2015年 | 2236篇 |
2014年 | 3785篇 |
2013年 | 4363篇 |
2012年 | 3378篇 |
2011年 | 3543篇 |
2010年 | 2833篇 |
2009年 | 2768篇 |
2008年 | 2588篇 |
2007年 | 2480篇 |
2006年 | 2130篇 |
2005年 | 1914篇 |
2004年 | 1586篇 |
2003年 | 1218篇 |
2002年 | 1031篇 |
2001年 | 981篇 |
2000年 | 783篇 |
1999年 | 617篇 |
1998年 | 446篇 |
1997年 | 407篇 |
1996年 | 372篇 |
1995年 | 397篇 |
1994年 | 376篇 |
1993年 | 370篇 |
1992年 | 328篇 |
1991年 | 281篇 |
1990年 | 254篇 |
1989年 | 248篇 |
1988年 | 242篇 |
1987年 | 182篇 |
1986年 | 168篇 |
1985年 | 179篇 |
1984年 | 190篇 |
1983年 | 75篇 |
1982年 | 158篇 |
1981年 | 103篇 |
1980年 | 126篇 |
1979年 | 68篇 |
1978年 | 62篇 |
1977年 | 49篇 |
1976年 | 39篇 |
1970年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
51.
52.
53.
消渴病与饮食关系密切,关于消渴病发病及治疗过程中的饮食、服药宜忌古已有之。其思想发源于《内经》,具体论述始于《伤寒杂病论》,在魏晋南北朝时期的诸多医籍中不断积累完善,到了唐代《外台秘要》和《医心方》时已经比较成熟,能够自成体系。通过系统总结唐以前医籍所载关于消渴病饮食及服药宜忌内容,分析其内在规律,有助于扩展和加深对糖尿病饮食宜忌相关的学术研究。 相似文献
55.
56.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献57.
Z.Y. Yu J. Geng Z.Q. Li Y.B. Sun S.L. Wang J. Masters D.X. Wang X.Y. Guo M. Li D. Ma 《British journal of anaesthesia》2019,122(1):141-149
Background
Previous studies suggest that dexmedetomidine has a protective effect against local anaesthetic-induced nerve injury in regional nerve blocks. Whether this potentially protective effect exists in the context of diabetes mellitus is unknown.Methods
A diabetic state was established in adult male Sprague–Dawley rats with intraperitoneal injection of streptozotocin. Injections of ropivacaine 0.5%, dexmedetomidine 20 μg kg?1 (alone and in combination), or normal saline (all in 0.2 ml) were made around the sciatic nerve in control and diabetic rats (n=8 per group). The duration of sensory and motor nerve block and the motor nerve conduction velocity (MNCV) were determined. Sciatic nerves were harvested at post-injection day 7 and assessed with light and electron microscopy or used for pro-inflammatory cytokine measurements.Results
Ropivacaine and dexmedetomidine alone or in combination did not produce nerve fibre damage in control non-diabetic rats. In diabetic rats, ropivacaine induced significant nerve fibre damage, which was enhanced by dexmedetomidine. This manifested with slowed MNCV, decreased axon density, and decreased ratio of inner to outer diameter of the myelin sheath (G ratio). Demyelination, axon disappearance, and empty vacuoles were also found using electron microscopy. An associated increase in nerve interleukin-1β and tumour necrosis factor-α was also seen.Conclusions
Ropivacaine 0.5% causes significant sciatic nerve injury in diabetic rats that is greatly potentiated by high-dose dexmedetomidine. Although the dose of dexmedetomidine used in this study is considerably higher than that used in clinical practice, our data suggest that further studies to assess ropivacaine (alone and in combination with dexmedetomidine) use for peripheral nerve blockade in diabetic patients are warranted. 相似文献58.
59.
Milan Milojevic Patrick W. Serruys Joseph F. Sabik David E. Kandzari Erick Schampaert Ad J. van Boven Ferenc Horkay Imre Ungi Samer Mansour Adrian P. Banning David P. Taggart Manel Sabaté Anthony H. Gershlick Andrzej Bochenek Jose Pomar Nicholas J. Lembo Nicolas Noiseux John D. Puskas Arie Pieter Kappetein 《Journal of the American College of Cardiology》2019,73(13):1616-1628
Background
The randomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a similar rate of the 3-year composite primary endpoint of death, myocardial infarction (MI), or stroke in patients with left main coronary artery disease (LMCAD) and site-assessed low or intermediate SYNTAX scores treated with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Whether these results are consistent in high-risk patients with diabetes, who have fared relatively better with CABG in most prior trials, is unknown.Objectives
In this pre-specified subgroup analysis from the EXCEL trial, the authors sought to examine the effect of diabetes in patients with LMCAD treated with PCI versus CABG.Methods
Patients (N = 1,905) with LMCAD and site-assessed low or intermediate CAD complexity (SYNTAX scores ≤32) were randomized 1:1 to PCI with everolimus-eluting stents versus CABG, stratified by the presence of diabetes. The primary endpoint was the rate of a composite of all-cause death, stroke, or MI at 3 years. Outcomes were examined in patients with (n = 554) and without (n = 1,350) diabetes.Results
The 3-year composite primary endpoint was significantly higher in diabetic compared with nondiabetic patients (20.0% vs. 12.9%; p < 0.001). The rate of the 3-year primary endpoint was similar after treatment with PCI and CABG in diabetic patients (20.7% vs. 19.3%, respectively; hazard ratio: 1.03; 95% confidence interval: 0.71 to 1.50; p = 0.87) and nondiabetic patients (12.9% vs. 12.9%, respectively; hazard ratio: 0.98; 95% confidence interval: 0.73 to 1.32; p = 0.89). All-cause death at 3 years occurred in 13.6% of PCI and 9.0% of CABG patients (p = 0.046), although no significant interaction was present between diabetes status and treatment for all-cause death (p = 0.22) or other endpoints, including the 3-year primary endpoint (p = 0.82) or the major secondary endpoints of death, MI, or stroke at 30 days (p = 0.61) or death, MI, stroke, or ischemia-driven revascularization at 3 years (p = 0.65).Conclusions
In the EXCEL trial, the relative 30-day and 3-year outcomes of PCI with everolimus-eluting stents versus CABG were consistent in diabetic and nondiabetic patients with LMCAD and site-assessed low or intermediate SYNTAX scores.(Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776) 相似文献60.
Yanhong Zhang Congxin Sun Caixia Jiang Wei Zhao Weijing Wang Qingying Cao Shuping Ge 《Echocardiography (Mount Kisco, N.Y.)》2019,36(2):415-418
Caudal regression syndrome (CRS) is a rare congenital malformation with varying degrees of early gestational developmental failure. It is characterized by agenesis of the sacrum and lumbar spine, with lower limb neurological deficit and accompanying deformities of the pelvis, lower extremities, genitourinary, and gastrointestinal systems. We report a case of CRS associated with rare complex congenital heart defect, that is, heterotaxy syndrome, diagnosed prenatally. 相似文献